arrow
M

Mitchell Sabloff

University of Ottawa
H指数:33
被引数:4,336

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective

急性髓系白血病患者在开始使用阿扎胞苷和维奈克拉治疗期间肿瘤溶解综合征的发生率:一项来自加拿大单中心视角的回顾性病历研究

2025-04-020
OA
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
2024-01-0115
PRE
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

在接受异基因造血干细胞移植的老年b细胞急性淋巴细胞白血病患者中,与年长的同胞供者相比,年轻的匹配的无关供者的复发风险降低

2023-10-0115
OAAI
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia

供者年龄对老年急性髓系白血病异基因造血干细胞移植结局的影响

2023-09-0112
OAAI
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
2022-08-188
OAAI
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes

氟达拉滨和美法仑与减少剂量的白消安和氟达拉滨相比,可改善老年骨髓增生异常综合征患者的移植结局

2021-11-0118
OAAI
Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults

打破年龄障碍: 医生对老年人异基因造血细胞移植的候选资格的看法

2021-07-0121
OAAI
Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study
2021-05-256
OA
Revised 15-item MDS-specific frailty scale maintains prognostic potential

修订后的15项MDS特定虚弱量表可维持预后潜力

LEUKEMIA
IF13.4
2020-08-2812
PREAI
An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring
LEUKEMIA
IF13.4
2019-12-0626
PREAI
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy

靶向MTF2-MDM2轴使难治性急性髓系白血病对化疗敏感

2018-11-0140
OAAI
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche

急性髓性白血病通过破坏脂肪细胞骨髓小生境来破坏内源性骨髓-红细胞生成

2017-10-16152
PREAI
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

骨髓增生异常综合征对促红细胞生成素刺激剂反应的预测模型: 来自加拿大MDS患者登记处

2017-10-0314
PREAI
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems

ITACA: 一种新的经过验证的国际促红细胞生成素刺激剂反应评分,进一步完善了以前评分系统的预测能力

2017-07-2919
OAAI
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

免疫消融和自体造血干细胞移植治疗侵袭性多发性硬化症: 一项多中心单组2期试验

LANCET
IF88.5
2016-08-01244
PREAI